Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Sciwind Biosciences Announces Positive Topline Results from Phase 3 Clinical Trial of Ecnoglutide (XW003), a Long-acting cAMP Signaling Biased GLP-1 Analog, in Adult Patients with Type 2 Diabetes in China
2024-01-03 10:00
Macau's Spectacular New Year Concert Sets a New Benchmark in Asian Entertainment at Galaxy Arena
2024-01-03 09:46
USI Upgraded its Intelligent Manufacturing Lights-Off Factory To A New Scale
2024-01-03 07:00
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval
2024-01-02 20:30
JW Therapeutics Announces Exclusive Collaboration with 2seventy bio for Autoimmune Disease CAR-T Therapy
2024-01-02 20:15
Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis
2024-01-02 20:06
Shanghai launches new online portal for expat services
2024-01-02 18:30
JA Solar Successfully Completes the Shipment of All n-type Modules for the ACWA Power Solar Project in Tashkent, Uzbekistan
2024-01-02 14:41
ZEASN Appoints Mike Duin as VP Global Marketing & Communications
2024-01-02 12:00
Global Times: County in E.China's Jiangxi Province implements policies to boost tea exports
2024-01-02 11:01
Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing
2024-01-02 10:06
Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
2024-01-02 08:00
CGTN: How Chinese modernization brings new opportunities to world
2024-01-01 20:31
CGTN: Embracing 2024, how will China deliver a better life for the people?
2024-01-01 20:27
Xi pledges to work with international society to build community with a shared future for mankind
2024-01-01 15:50
State Grid Dezhou Power Supply Company: Electric empowerment provides "full grid electricity" for local economic development
2024-01-01 00:01
Between the beautiful Xixi National Wetland Park
2023-12-29 21:46
Petal Maps and Tawasal SuperApp Join Forces for a forward thinking maps service, setting the foundation for Building a Global In-Car Solution Ecosystem
2023-12-29 20:06
NOAH Announces Change of Chief Executive Officer
2023-12-29 19:00
What Hebei Can Offer丨From Hebei to the World: A Dairy Industry Journey
2023-12-29 16:49
1
166
167
168
169
170
1250